Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $2 | $24 | $1,614 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $2 | $24 | $1,614 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 29.9% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.1% | 39% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -736.3% | -1,468.7% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,288.3% | -1,501.8% | – | – |
| EPS Diluted | -176.6 | -6,368.84 | -811.68 | -163,968 |
| % Growth | 97.2% | -684.6% | 99.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |